EISSN 2148-5607

TJG IS INDEXED IN SCI-EXPANDED AND PUBMED IMPACT FACTOR: 1.4

Turkish Journal of Gastroenterology

35 414 2024

HIGHLY CITED ARTICLES

HBV and HCV are the risk factors in CCA

Tan et al.

Serum resolvin levels in irritable bowel syndrome

Karatay and Gül Utku

Microbial improvement after intervention

Qian et al.

18F-FDGPET/CT in gallbladder carcinoma

Arslan et al.

Bezoar in endoscopy

Gökbulut et al.

Effect of vitamin D on CD40L gene expression in UC

Sharifi et al.

ERCP for acute cholangitis

Khamaysi and Taha

Inborn metabolic causes of fatty liver disease

Yıldız and Sivri

Gastric and small intestinal TSA

Kiremitci et al.

COVID-19 in Hepatology and Liver transplantation

Kabaçam et al.

Submission to First Decision = 31 Days

FIBRINOLYTIC ACTNITY IN INFLAMATORY BOWEL DISEASE

Uğur YILMAZ ¹ , Selim AYAZ ² , Ahmet TEZEL ² , Hülya ÖVER ² , Azmi SERİN ² , Leziz ONARAN ³

Author Affiliation(s)

1.

Türkiye Yüksek İhtisas Hastanesi Gastroenteroloji Kliniği, Ankara

2.

Türkiye Yüksek İhtisas Hastanesi, Gastroenteroloji Kliniği, Ankara

3.

Türkiye Yüksek İhtisas Hastanesi lnflamatuvar Barsak Hastalıkları Ünitesi, Ankara

Turk J Gastroenterol 1994; 5: 723-726

Keywords : Inflammatory Bowel Disease, Pathogenesis, Fibrinolysis, Tissue Plasminogen Activator, Plasminogen Activator

Read: 942 Downloads: 659 Published: 24 April 2020

Volume 5, Issue 4, September 1994

Previous Article

Files